$LOAN

Quarterly income rose 3%, but nine-month profit fell 8.1%.

Manhattan Bridge Capital (LOAN) reported a 3% rise in quarterly net income to $1.24M, but a 8.1% drop in nine-month profit to $3.67M. Total revenues for the quarter were $2.05M, while nine-month revenues fell to $6.17M. The company expanded its share repurchase program to 250,000 shares, extending it to October 2027. CEO Assaf Ran noted pressure from rising interest rates on real estate markets.

Original reporting
Published Oct 21, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LOAN
Bullish
high confidence
Mentioned
$LOAN
Relevance
6/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$LOANBullishMed
01

Why it matters

The Q3 earnings release and expanded share repurchase program provide fresh data for valuation and short‑term trading decisions.

02

Market read

A small‑cap earnings release with a buyback expansion; relevant for niche lenders and micro‑cap traders.

03

What to watch

Potential impact of rising interest rates on loan demand and default risk is not fully reflected in the release.

Relevance 6/10Novelty 7/10Timing: pre-market today

Background

Manhattan Bridge Capital is a short‑term secured loan provider focused on real‑estate investors in the NY metro area and Florida.

Company-level read

Ticker impact

$LOANBullishHigh confidence
Context

Manhattan Bridge Capital reported its Q3 2026 revenue and net income, and announced an expanded share repurchase program.

Expected impact

likely modest upside as investors price in higher earnings and increased buyback capacity

Evidence & confidence

New earnings numbers and a larger buyback program are fresh primary information that can move the price in the short term.

Market effects

Provides a data point for the niche hard‑money loan sector, but impact is limited to small‑cap lenders.

Primarily affects U.S. small‑cap investors; no broader regional effect.

Low global relevance.

Counterpoint

The modest revenue decline and higher operating costs could signal margin pressure despite the buyback.

Key entities

  • Manhattan Bridge Capital, Inc.

    Issuer of the earnings release and share repurchase program.

  • Assaf Ran

    Chairman and CEO who commented on the results.

Related articles

$LOANMedAI 8/10

Manhattan Bridge Capital (NASDAQ:LOAN) Share Price Passes Below 200

Manhattan Bridge Capital (NASDAQ:LOAN) shares fell below their 200-day moving average during Wednesday trading, dipping to $4.18 and last trading at $4.23 versus a 200-day average of $4.52. Weiss Ratings downgraded LOAN from “hold (c)” to “hold (c-)” on May 11. The company reported Q1 EPS of $0.11 (vs. $0.12) and revenue of $2.07M (vs. $2.18M), and declared a $0.11 quarterly dividend payable July 15.

$BCPCMedAI 8/10

Balchem Corp (BCPC) Q3 2026 Earnings Call Highlights: Record Revenue, 29th Straight

Balchem Corp (BCPC) reported Q3 2026 record revenue of $291M, up 8.6%, with all segments growing. EBITDA rose 12.4% to $80M, marking 29 straight quarters of growth. The company faces inflationary pressures and seasonality challenges but expects year-over-year growth in Q4. Inventory increased to $177M due to inflation and growth. Clinical trials in Alzheimer's and cardiovascular health show promise, with marketing efforts planned. BCPC's effective tax rate is expected to be 22.5-23%.